"Having a confirmed Type C meeting now establishes a clear timetable and in parallel we are continuing all our preparations, planning for mid-year commencement of the first ever Phase 3 trial for children with Phelan-McDermid syndrome"
I stand by my comment that both parties would now be in agreement on the endpoints. How could JP make the above comment if they weren't?
Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-32
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.51 |
Change
0.250(2.04%) |
Mkt cap ! $1.525B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.52 | $12.44 | $68.14K | 5.443K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 442 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.52 | 136 | 2 |
View Market Depth
| Last trade - 10.01am 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |